Julie Gerberding

Julie Gerberding

Director/Board Member bei HILLEVAX, INC.

Vermögen: 698 876 $ am 31.03.2024

69 Jahre
Health Technology
Commercial Services
Health Services

Profil

Julie Louise Gerberding is currently the President, Chief Executive Officer & Director at the Foundation for the National Institutes of Health, Inc. She is also a Director at the Biotechnology Innovation Organization, Accordia Global Health Foundation, MSD Wellcome Trust Hilleman Laboratories Pvt Ltd., SummerBio LLC, Afternext Healthtech Acquisition Corp., HilleVax, Inc., and a Trustee at Case Western Reserve University and Mayo Clinic.
Additionally, she is a Member of the National Academy of Public Administration and the National Academy of Medicine (United States).
In her former positions, Dr. Gerberding served as the Co-Chairman at MSD Vaccines Ltd.
She was an Independent Director at Cerner Corp.
from 2017 to 2022.
From 1998 to 2009, she worked at the Centers for Disease Control & Prevention, where she served as the Director from 2002 to 2009.
She was also a Director at Project HOPE-The-People-To-People Health Foundation, Inc. and Executive Vice President-Strategic Communications at Merck & Co., Inc. from 2015 to 2016.
Additionally, she was the President of Merck Vaccine Division from 2010 to 2014.
Dr. Gerberding received her undergraduate and doctorate degrees from Case Western Reserve University.
She also holds a graduate degree from the University of California, Berkeley, which she obtained in 1990.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
07.06.2023 42 025 ( 0,08% ) 698 876 $ 31.03.2024

Aktive Positionen von Julie Gerberding

UnternehmenPositionBeginn
AFTERNEXT HEALTHTECH ACQUISITION CORP. Director/Board Member 16.08.2021
HILLEVAX, INC. Director/Board Member 01.04.2021
Director/Board Member 16.03.2022
Corporate Officer/Principal -
Chief Executive Officer 16.05.2022
Director/Board Member 01.01.2010
Director/Board Member -
Director/Board Member -
Corporate Officer/Principal -
░░░░░░░░ ░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Alle aktiven Positionen von Julie Gerberding

Ehemalige bekannte Positionen von Julie Gerberding

UnternehmenPositionEnde
░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░ ░░░░░░░ ░░░░░░░ ░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░░░ ░░░░░ ░░░░ ░░░░ ░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ -
Sehen Sie sich die Erfahrung von Julie Gerberding im Detail an

Ausbildung von Julie Gerberding

Case Western Reserve University Doctorate Degree
University of California, Berkeley Graduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Julie Gerberding im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

18

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen3
MERCK & CO., INC.

Health Technology

AFTERNEXT HEALTHTECH ACQUISITION CORP.

Finance

HILLEVAX, INC.

Health Technology

Private Unternehmen13

Technology Services

Commercial Services

Health Services

Government

Health Technology

Commercial Services

Health Services

Commercial Services

Commercial Services

Accordia Global Health Foundation

Miscellaneous

Merck Vaccine Division

Health Technology

Health Services

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Julie Gerberding